Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Squamous Cell Carcinoma of the Head or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07546383
What this trial is testing

A Study Investigating the Efficacy and Safety of the Combination of Iparomlimab and Tuvonralimab With or Without Chemotherapy in Second-line and Subsequent Treatments for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
The Second Affiliated Hospital of Hainan Medical University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06857279
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Carcinoma of Head and/or Neck
Shanghai Henlius Biotech 167
Testing effectiveness (Phase 2)Ended earlyNCT04242173
What this trial is testing

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and Neck
H. Lee Moffitt Cancer Center and Research Institute 3
Not applicableEnded earlyNCT00898742
What this trial is testing

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT04868162
What this trial is testing

Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Lepu Biopharma Co., Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT03433027
What this trial is testing

BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Benitec Biopharma, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT03109158
What this trial is testing

NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
NanoCarrier Co., Ltd. 1
Testing effectiveness (Phase 2)Study completedNCT01417936
What this trial is testing

Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Symphogen A/S 26
Not applicableStudy completedNCT00963326
What this trial is testing

Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer

Who this might be right for
Head and Neck Cancer
Centre Oscar Lambret 30
Testing effectiveness (Phase 2)Study completedNCT00098631
What this trial is testing

Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Squamous Cell Carcinoma of the Hypopharynx+13 more
National Cancer Institute (NCI) 88
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Looking for participantsNCT07081984
What this trial is testing

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors

Who this might be right for
HPV 16+ Recurrent or Metastatic CancerHNSCCCervical Cancer
Therorna 12
Not applicableStudy completedNCT01075828
What this trial is testing

Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea

Who this might be right for
Head and Neck Cancer
Merck KGaA, Darmstadt, Germany 221
Testing effectiveness (Phase 2)Looking for participantsNCT07668154
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants

Who this might be right for
HNSCC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)UnknownNCT00003856
What this trial is testing

Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy

Who this might be right for
Head and Neck Cancer
Quintiles, Inc. 75
Early research (Phase 1)Active Not RecruitingNCT04470024
What this trial is testing

Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

Who this might be right for
Cancer of the Head and Neck
Providence Health & Services 19
Testing effectiveness (Phase 2)Study completedNCT00492089
What this trial is testing

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Meningioma+84 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT00103259
What this trial is testing

Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+22 more
National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT00494182
What this trial is testing

Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Squamous Cell Carcinoma of the HypopharynxMetastatic Squamous Cell Carcinoma of the Larynx+7 more
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT00055913
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more
National Cancer Institute (NCI) 58
Next Page